Literature DB >> 3177367

Acute lymphoblastic leukemia in a patient with longstanding polycythemia vera: cytogenetic analysis reveals two distinct abnormal clones.

J Anastasi1, M J Pettenati, M M Le Beau, H C Kwaan, S C Weil.   

Abstract

A 68-year-old female patient is described in whom acute lymphoblastic leukemia followed a long course of polycythemia vera. Chromosomal analysis of a peripheral blood specimen at the time of blastic transformation revealed two distinct clones: one characterized by a chromosomal abnormality frequently noted in polycythemia vera and the other by a rearrangement characteristically observed in lymphoid malignancies. These findings suggest the existence of two independent hematologic diseases: this phenomenon would not support the speculation from previous reports that lymphoproliferative disorders in patients with polycythemia vera arise from clonal evolution.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3177367     DOI: 10.1002/ajh.2830290108

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  4 in total

1.  Acute Lymphoblastic Leukemia Transformation in Polycythemia Vera: A Rare Phenomenon.

Authors:  Władysław B Gaweł; Grzegorz Helbig; Kinga Boral; Sławomira Kyrcz-Krzemień
Journal:  Indian J Hematol Blood Transfus       Date:  2016-03-24       Impact factor: 0.900

2.  Acute Lymphoblastic Leukemia in the Course of Polycythemia Vera: A Case Report and Review of Literature.

Authors:  Dijiong Wu; Baodong Ye; Jianping Shen; Laijun Peng; Zhiqiang Zhong; Yuhong Zhou
Journal:  Indian J Hematol Blood Transfus       Date:  2015-09-21       Impact factor: 0.900

3.  Acute Lymphoblastic Leukemia Arising in CALR Mutated Essential Thrombocythemia.

Authors:  Stephen E Langabeer; Karl Haslam; David O'Brien; Johanna Kelly; Claire Andrews; Ciara Ryan; Richard Flavin; Patrick J Hayden; Christopher L Bacon
Journal:  Case Rep Hematol       Date:  2016-01-21

4.  Acute lymphoblastic leukemia secondary to myeloproliferative neoplasms or after lenalidomide exposure.

Authors:  Ahmad Alhuraiji; Kiran Naqvi; Yang O Huh; Coty Ho; Srdan Verstovsek; Prithviraj Bose
Journal:  Clin Case Rep       Date:  2017-12-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.